The application belongs to the technical field of
disease detection, and particularly relates to application of
triphenylmethane compounds in detection of Alzheimer's
disease. The application is accidentally discovered that
triphenylmethane compounds, especially
crystal violet, can be inserted into misfolded beta-sheets of A beta oligomers, so as to cause change of spectrum. Macroscopically, oxidation and discoloration are caused, so that the
triphenylmethane compounds can be used for monitoring and early screening of Alzheimer's
disease patients. Compared with
antigen-
antibody preparation of
antigen-
antibody immunoreaction products, the product in the application has the defects of complicated
antigen-
antibody preparation and high cost, and the product in the application has low cost. Meanwhile, the main component of the application is a chemical
reagent, has good stability, does not need
refrigeration storage condition, is convenient to transport, and is convenient to use. Meanwhile, the technical scheme of the application effectively avoids the cleaning process of
enzyme-labeled plates and
chemiluminescence experiments, and does not need special equipment, so that the basic medical institutions can use the application, and therefore the application has good practical application value and application prospect.